Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Arch Biopartners

    Client Virtual Booth

    ARCH BIOPARTNERS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Arch Biopartners
    Canada Flag
    Country
    Country
    Canada
    Address
    Address
    27 St. Clair Avenue East P.O. Box 305 Toronto, Ontario, M4T 2M5 Canada
    Telephone
    Telephone
    +1 647 428 7031
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://archbiopartners.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/arch-biopartners-inc-foiff-
    Twitter
    Twitter
    https://twitter.com/archbiopartners

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    St. Michael's Hospital Joins LSALT Peptide Phase II Cardiac Surgery AKI Trial
    St. Michael's Hospital Joins LSALT Peptide Phase II Cardiac Surgery AKI Trial

    https://www.globenewswire.com/news-release/2024/04/16/2863477/0/en/St-Michael-s-Hospital-Joins-the-Phase-II-Trial-of-LSALT-Peptide-Targeting-Cardiac-Surgery-Associated-Acute-Kidney-Injury.html

    GLOBENEWSWIRE
    16 Apr 2024
    Share Share
    UHN Joins the Ph II Trial of LSALT Pept-Targeting Cardiac Surgery Associated AKI
    UHN Joins the Ph II Trial of LSALT Pept-Targeting Cardiac Surgery Associated AKI

    https://www.globenewswire.com/news-release/2024/04/03/2856777/0/en/UHN-Joins-the-Phase-II-Trial-of-LSALT-Peptide-Targeting-Cardiac-Surgery-Associated-Acute-Kidney-Injury.html

    GLOBENEWSWIRE
    03 Apr 2024
    Share Share
    Arch Biopartners Adds Three New Clinical Sites into the Phase II Trial for LSALT
    Arch Biopartners Adds Three New Clinical Sites into the Phase II Trial for LSALT

    https://www.globenewswire.com/news-release/2024/04/02/2855829/0/en/Arch-Biopartners-Adds-Three-New-Clinical-Sites-into-the-Phase-II-Trial-for-LSALT-Peptide-Targeting-Cardiac-Surgery-Associated-Acute-Kidney-Injury.html

    GLOBENEWSWIRE
    02 Apr 2024
    Share Share
    Arch Biopartners Team Publishes Data from Phase II Trial for LSALT Peptide
    Arch Biopartners Team Publishes Data from Phase II Trial for LSALT Peptide

    https://www.globenewswire.com/news-release/2024/03/18/2847692/0/en/Arch-Biopartners-Clinical-Team-Publishes-Data-from-Phase-II-Trial-for-LSALT-Peptide-Targeting-Organ-Inflammation-in-Hospitalized-Patients-Infected-with-SARS-CoV-2.html

    GLOBENEWSWIRE
    18 Mar 2024
    Share Share
    University of Calgary Joins the Ph II of LSALT Peptide Targeting Kidney Injury
    University of Calgary Joins the Ph II of LSALT Peptide Targeting Kidney Injury

    https://www.globenewswire.com//news-release/2024/03/15/2846964/0/en/University-of-Calgary-Joins-the-Phase-II-Trial-of-LSALT-Peptide-Targeting-Cardiac-Surgery-Associated-Acute-Kidney-Injury.html

    GLOBENEWSWIRE
    15 Mar 2024
    Share Share
    Arch Bio Announces Dosing of First Patient in Phase II Trial for LSALT Peptide
    Arch Bio Announces Dosing of First Patient in Phase II Trial for LSALT Peptide

    https://www.globenewswire.com//news-release/2024/03/07/2842126/0/en/Arch-Biopartners-Announces-Dosing-of-First-Patient-in-Phase-II-Trial-for-LSALT-Peptide-Targeting-Cardiac-Surgery-Associated-Acute-Kidney-Injury.html

    GLOBENEWSWIRE
    07 Mar 2024
    Share Share
    Arch Biopartners Has Pre-IND Meeting With FDA to Discuss Repurposing Cilastatin
    Arch Biopartners Has Pre-IND Meeting With FDA to Discuss Repurposing Cilastatin

    https://www.globenewswire.com//news-release/2024/02/27/2835883/0/en/Arch-Biopartners-Has-Pre-IND-Meeting-With-FDA-to-Discuss-Repurposing-Cilastatin-as-a-New-Treatment-to-Prevent-Acute-Kidney-Injury.html

    GLOBENEWSWIRE
    27 Feb 2024
    Share Share
    Arch Receives Health Canada Approval to Conduct PII Trial for LSALT Peptide
    Arch Receives Health Canada Approval to Conduct PII Trial for LSALT Peptide

    https://www.globenewswire.com//news-release/2024/01/10/2806998/0/en/Arch-Biopartners-Receives-Health-Canada-Approval-to-Conduct-Phase-II-Trial-for-LSALT-Peptide-Targeting-Cardiac-Surgery-Associated-Acute-Kidney-Injury.html

    GLOBENEWSWIRE
    10 Jan 2024
    Share Share
    Arch Biop Receives Approval to Proceed with Phase II Trial for LSALT Peptide
    Arch Biop Receives Approval to Proceed with Phase II Trial for LSALT Peptide

    https://www.globenewswire.com//news-release/2024/01/03/2803202/0/en/Arch-Biopartners-Receives-Approval-from-the-Turkish-Ministry-of-Health-to-Proceed-with-Phase-II-Trial-for-LSALT-Peptide-Targeting-Cardiac-Surgery-Associated-Acute-Kidney-Injury.html

    GLOBENEWSWIRE
    03 Jan 2024
    Share Share
    Arch Biopartners Receives Approval to Proceed with Phase II Kidney Injury Trial
    Arch Biopartners Receives Approval to Proceed with Phase II Kidney Injury Trial

    https://www.globenewswire.com//news-release/2023/12/21/2799927/0/en/Arch-Biopartners-Receives-Approval-from-Ethics-Committee-in-Turkey-to-Proceed-with-Phase-II-Cardiac-Surgery-Associated-Acute-Kidney-Injury-Trial-for-LSALT-Peptide.html

    GLOBENEWSWIRE
    21 Dec 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search